©The Author(s) 2022.
World J Psychiatry. May 19, 2022; 12(5): 693-707
Published online May 19, 2022. doi: 10.5498/wjp.v12.i5.693
Published online May 19, 2022. doi: 10.5498/wjp.v12.i5.693
Table 1 Demographic and clinical characteristics of patients with treatment-resistant schizophrenia and healthy controls
| Characteristics | TRS (n = 50) | HCs (n = 61) | P value |
| Age (yr) | 42.64 (9.79) | 39.89 (9.52) | 0.137 |
| Sex | |||
| Male (%) | 32 (64%) | 29 (48%) | 0.083 |
| Female (%) | 18 (36%) | 32 (52%) | |
| Education (years) | 13.53 (2.27) | 13.33 (1.92) | 0.613 |
| Duration of illness (mo) | 215.22 (110.09) | - | - |
| PANSS | |||
| Positive symptoms | 15.96 (4.99) | - | - |
| Negative symptoms | 16.00 (7.30) | - | - |
| General psychopathology | 28.40 (7.74) | - | - |
| Total | 60.36 (17.52) | - | - |
| SOFAS | 49.00 (8.81) | - | - |
| Medication | |||
| Chlorpromazine equivalent (mg/d) | 915.33 (411.41) | - | - |
- Citation: Kim WS, Shen J, Tsogt U, Odkhuu S, Chung YC. Altered thalamic subregion functional networks in patients with treatment-resistant schizophrenia. World J Psychiatry 2022; 12(5): 693-707
- URL: https://www.wjgnet.com/2220-3206/full/v12/i5/693.htm
- DOI: https://dx.doi.org/10.5498/wjp.v12.i5.693